Eur J Nucl Med Mol Imaging (2017) 44 (Suppl 1):S1–S3 DOI 10.1007/s00259-017-3721-5 EDITORIAL Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community 1,2,3 3,4 Nicolas Aide & Stefano Fanti Received: 3 May 2017 /Accepted: 5 May 2017 /Published online: 24 May 2017 Springer-Verlag Berlin Heidelberg 2017 It has been 18 years since the first guidelines on PET response We have divided the issue into four sections. The first sec- criteria were released  (with little supporting data at that tion includes a recent update on PET technologies and two time) and 15 years since the first successful use of PET for articles discussing the motivations and methodology for har- evaluation of a molecularly targeted therapy (imatinib) was monization of PET data and the challenges faced when published . This latter study demonstrated the huge poten- implementing PET in clinical trials. It is followed by a section tial of PET imaging in assessing tumor response early after including a practical guide to better understand molecularly treatment initiation, at a time when conventional criteria based targeted therapies, and a comprehensive review on the use of on size measurements (RECIST) were found to be unsatisfac-
European Journal of Nuclear Medicine and Molecular Imaging – Springer Journals
Published: May 24, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera